[{"edinetCode":"E00970","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":687.0,"averageTemporaryStaff":155.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":28387000.0,"sharesOwendPercent":0.4997,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":1248.07,"equityRatio":0.883,"cashAndCashEquivalents":8460000000.0,"assets":80048000000.0,"currentAssets":28186000000.0,"fixedAsset":51861000000.0,"tangibleFixedAssets":22716000000.0,"intangibleFixedAssets":479000000.0,"investmentAndOtherAssets":28665000000.0,"liabilities":9401000000.0,"currentLiabilities":6194000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":285000000.0,"fixedLiabilities":3207000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":142000000.0,"netAsset":70646000000.0,"capitalStock":66420000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":57622000000.0,"treasuryStock":-344000000.0,"valuationAndConversionAdjustments":4225000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":29589000000.0,"costOfSales":13247000000.0,"grossProfit":16341000000.0,"sgaExpenses":15059000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":7834000000.0,"operatingIncome":1282000000.0,"nonOperatingIncome":1347000000.0,"nonOperatingExpenses":152000000.0,"interestExpense":31000000.0,"ordinaryProfit":2477000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":2477000000.0,"incomeTaxes":689000000.0,"netIncome":1787000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1787000000.0,"comprehensiveIncome":2638000000.0,"eps":31.55,"dilutedEps":null,"dividendPerShare":null,"per":58.8,"roe":0.025,"cashFlowFromOperatingActivities":4885000000.0,"depreciationAndCashflowFromOperatingActivities":2920000000.0,"cashFlowFromInvestingActivities":-3502000000.0,"cashFlowFromFinancialActivities":-2282000000.0,"changesInCashAndCashEquivalents":-1033000000.0,"列1":"asr","submitDate":"2017\/6\/20","stockCode":4548,"accountingYear":"第71期（自 平成28年4月1日　至 平成29年3月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":718.0,"averageTemporaryStaff":125.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":27886000.0,"sharesOwendPercent":0.4927,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":1306.37,"equityRatio":0.873,"cashAndCashEquivalents":7511000000.0,"assets":84749000000.0,"currentAssets":30942000000.0,"fixedAsset":53806000000.0,"tangibleFixedAssets":21275000000.0,"intangibleFixedAssets":554000000.0,"investmentAndOtherAssets":31977000000.0,"liabilities":10803000000.0,"currentLiabilities":7675000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":142000000.0,"fixedLiabilities":3127000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":73945000000.0,"capitalStock":68587000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":59790000000.0,"treasuryStock":-344000000.0,"valuationAndConversionAdjustments":5357000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":30175000000.0,"costOfSales":13008000000.0,"grossProfit":17166000000.0,"sgaExpenses":15745000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":8408000000.0,"operatingIncome":1421000000.0,"nonOperatingIncome":3970000000.0,"nonOperatingExpenses":65000000.0,"interestExpense":27000000.0,"ordinaryProfit":5327000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":5327000000.0,"incomeTaxes":1404000000.0,"netIncome":3922000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3922000000.0,"comprehensiveIncome":5054000000.0,"eps":69.3,"dilutedEps":null,"dividendPerShare":null,"per":28.0,"roe":0.054,"cashFlowFromOperatingActivities":5346000000.0,"depreciationAndCashflowFromOperatingActivities":2926000000.0,"cashFlowFromInvestingActivities":-4066000000.0,"cashFlowFromFinancialActivities":-2221000000.0,"changesInCashAndCashEquivalents":-948000000.0,"列1":"asr","submitDate":"2018\/6\/20","stockCode":4548,"accountingYear":"第72期（自 2017年4月1日　至 2018年3月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":744.0,"averageTemporaryStaff":110.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":28376000.0,"sharesOwendPercent":0.5031,"outstandingShares":null,"numberOfSubsidiary":3.0,"bps":1294.88,"equityRatio":0.91,"cashAndCashEquivalents":7313000000.0,"assets":80238000000.0,"currentAssets":34390000000.0,"fixedAsset":45848000000.0,"tangibleFixedAssets":19656000000.0,"intangibleFixedAssets":577000000.0,"investmentAndOtherAssets":25614000000.0,"liabilities":7202000000.0,"currentLiabilities":5357000000.0,"shorTermDept":300000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1844000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":73036000000.0,"capitalStock":69060000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":60566000000.0,"treasuryStock":-647000000.0,"valuationAndConversionAdjustments":3975000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":28384000000.0,"costOfSales":13114000000.0,"grossProfit":15270000000.0,"sgaExpenses":14292000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":7148000000.0,"operatingIncome":977000000.0,"nonOperatingIncome":1984000000.0,"nonOperatingExpenses":102000000.0,"interestExpense":22000000.0,"ordinaryProfit":2859000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":2859000000.0,"incomeTaxes":614000000.0,"netIncome":2244000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2244000000.0,"comprehensiveIncome":862000000.0,"eps":39.76,"dilutedEps":null,"dividendPerShare":null,"per":30.2,"roe":0.031,"cashFlowFromOperatingActivities":3121000000.0,"depreciationAndCashflowFromOperatingActivities":2902000000.0,"cashFlowFromInvestingActivities":-1481000000.0,"cashFlowFromFinancialActivities":-1812000000.0,"changesInCashAndCashEquivalents":-198000000.0,"列1":"asr","submitDate":"2019\/6\/19","stockCode":4548,"accountingYear":"第73期（自 2018年4月1日　至 2019年3月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.919,"cashAndCashEquivalents":null,"assets":79488000000.0,"currentAssets":36038000000.0,"fixedAsset":43450000000.0,"tangibleFixedAssets":19026000000.0,"intangibleFixedAssets":575000000.0,"investmentAndOtherAssets":23848000000.0,"liabilities":6399000000.0,"currentLiabilities":4670000000.0,"shorTermDept":300000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1728000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":73089000000.0,"capitalStock":69307000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":60813000000.0,"treasuryStock":-647000000.0,"valuationAndConversionAdjustments":3781000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":7649000000.0,"costOfSales":3596000000.0,"grossProfit":4052000000.0,"sgaExpenses":3088000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1288000000.0,"operatingIncome":964000000.0,"nonOperatingIncome":421000000.0,"nonOperatingExpenses":134000000.0,"interestExpense":5000000.0,"ordinaryProfit":1251000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":1251000000.0,"incomeTaxes":270000000.0,"netIncome":980000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":980000000.0,"comprehensiveIncome":786000000.0,"eps":17.38,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/8","stockCode":4548,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":28582000.0,"sharesOwendPercent":0.5066,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.9,"cashAndCashEquivalents":12850000000.0,"assets":68151000000.0,"currentAssets":37761000000.0,"fixedAsset":30389000000.0,"tangibleFixedAssets":6244000000.0,"intangibleFixedAssets":470000000.0,"investmentAndOtherAssets":23674000000.0,"liabilities":6791000000.0,"currentLiabilities":4495000000.0,"shorTermDept":300000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2295000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":61359000000.0,"capitalStock":57576000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":49061000000.0,"treasuryStock":-627000000.0,"valuationAndConversionAdjustments":3783000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":15555000000.0,"costOfSales":6780000000.0,"grossProfit":8775000000.0,"sgaExpenses":6624000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3007000000.0,"operatingIncome":2150000000.0,"nonOperatingIncome":478000000.0,"nonOperatingExpenses":157000000.0,"interestExpense":9000000.0,"ordinaryProfit":2471000000.0,"extraordinaryGain":null,"extraordinaryLoss":12304000000.0,"incomeBeforeTax":-9833000000.0,"incomeTaxes":933000000.0,"netIncome":-10766000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-10766000000.0,"comprehensiveIncome":-10958000000.0,"eps":-190.86,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":3744000000.0,"depreciationAndCashflowFromOperatingActivities":1452000000.0,"cashFlowFromInvestingActivities":2748000000.0,"cashFlowFromFinancialActivities":-846000000.0,"changesInCashAndCashEquivalents":5537000000.0,"列1":"q2r","submitDate":"2019\/11\/14","stockCode":4548,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.891,"cashAndCashEquivalents":null,"assets":70128000000.0,"currentAssets":38720000000.0,"fixedAsset":31407000000.0,"tangibleFixedAssets":6247000000.0,"intangibleFixedAssets":461000000.0,"investmentAndOtherAssets":24698000000.0,"liabilities":7627000000.0,"currentLiabilities":5005000000.0,"shorTermDept":300000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2622000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":62501000000.0,"capitalStock":57827000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":49313000000.0,"treasuryStock":-627000000.0,"valuationAndConversionAdjustments":4673000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":23240000000.0,"costOfSales":10059000000.0,"grossProfit":13180000000.0,"sgaExpenses":9914000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":4457000000.0,"operatingIncome":3265000000.0,"nonOperatingIncome":732000000.0,"nonOperatingExpenses":129000000.0,"interestExpense":14000000.0,"ordinaryProfit":3868000000.0,"extraordinaryGain":null,"extraordinaryLoss":12441000000.0,"incomeBeforeTax":-8573000000.0,"incomeTaxes":1208000000.0,"netIncome":-9781000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-9781000000.0,"comprehensiveIncome":-9083000000.0,"eps":-173.4,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":4548,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":868.0,"averageTemporaryStaff":107.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":29006000.0,"sharesOwendPercent":0.5141,"outstandingShares":null,"numberOfSubsidiary":6.0,"bps":1059.4,"equityRatio":0.872,"cashAndCashEquivalents":14992000000.0,"assets":68501000000.0,"currentAssets":40447000000.0,"fixedAsset":28053000000.0,"tangibleFixedAssets":7662000000.0,"intangibleFixedAssets":1577000000.0,"investmentAndOtherAssets":18813000000.0,"liabilities":8734000000.0,"currentLiabilities":6707000000.0,"shorTermDept":376000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2027000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":59767000000.0,"capitalStock":56768000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":48254000000.0,"treasuryStock":-628000000.0,"valuationAndConversionAdjustments":2998000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":28642000000.0,"costOfSales":12513000000.0,"grossProfit":16129000000.0,"sgaExpenses":14169000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":6877000000.0,"operatingIncome":1960000000.0,"nonOperatingIncome":2535000000.0,"nonOperatingExpenses":514000000.0,"interestExpense":18000000.0,"ordinaryProfit":3981000000.0,"extraordinaryGain":null,"extraordinaryLoss":13524000000.0,"incomeBeforeTax":-9543000000.0,"incomeTaxes":1296000000.0,"netIncome":-10839000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-10839000000.0,"comprehensiveIncome":-11817000000.0,"eps":-192.15,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":-0.163,"cashFlowFromOperatingActivities":8670000000.0,"depreciationAndCashflowFromOperatingActivities":1778000000.0,"cashFlowFromInvestingActivities":623000000.0,"cashFlowFromFinancialActivities":-1603000000.0,"changesInCashAndCashEquivalents":7679000000.0,"列1":"asr","submitDate":"2020\/6\/29","stockCode":4548,"accountingYear":"第74期（自 2019年4月1日　至 2020年3月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.892,"cashAndCashEquivalents":null,"assets":67238000000.0,"currentAssets":39418000000.0,"fixedAsset":27820000000.0,"tangibleFixedAssets":7659000000.0,"intangibleFixedAssets":1581000000.0,"investmentAndOtherAssets":18579000000.0,"liabilities":7247000000.0,"currentLiabilities":5115000000.0,"shorTermDept":376000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2131000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":59991000000.0,"capitalStock":56565000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":48051000000.0,"treasuryStock":-628000000.0,"valuationAndConversionAdjustments":3426000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":6972000000.0,"costOfSales":3485000000.0,"grossProfit":3486000000.0,"sgaExpenses":3180000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1615000000.0,"operatingIncome":305000000.0,"nonOperatingIncome":342000000.0,"nonOperatingExpenses":37000000.0,"interestExpense":4000000.0,"ordinaryProfit":610000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":610000000.0,"incomeTaxes":80000000.0,"netIncome":529000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":529000000.0,"comprehensiveIncome":957000000.0,"eps":9.39,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/6","stockCode":4548,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":29489000.0,"sharesOwendPercent":0.5226,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.903,"cashAndCashEquivalents":14959000000.0,"assets":66981000000.0,"currentAssets":39928000000.0,"fixedAsset":27052000000.0,"tangibleFixedAssets":7792000000.0,"intangibleFixedAssets":1591000000.0,"investmentAndOtherAssets":17669000000.0,"liabilities":6497000000.0,"currentLiabilities":4377000000.0,"shorTermDept":378000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2120000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":60483000000.0,"capitalStock":56951000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":48416000000.0,"treasuryStock":-606000000.0,"valuationAndConversionAdjustments":3531000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":13533000000.0,"costOfSales":6120000000.0,"grossProfit":7413000000.0,"sgaExpenses":6694000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3535000000.0,"operatingIncome":718000000.0,"nonOperatingIncome":456000000.0,"nonOperatingExpenses":76000000.0,"interestExpense":8000000.0,"ordinaryProfit":1098000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":1098000000.0,"incomeTaxes":121000000.0,"netIncome":976000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":976000000.0,"comprehensiveIncome":1509000000.0,"eps":17.3,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-209000000.0,"depreciationAndCashflowFromOperatingActivities":369000000.0,"cashFlowFromInvestingActivities":1149000000.0,"cashFlowFromFinancialActivities":-837000000.0,"changesInCashAndCashEquivalents":-33000000.0,"列1":"q2r","submitDate":"2020\/11\/13","stockCode":4548,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.904,"cashAndCashEquivalents":null,"assets":66664000000.0,"currentAssets":41111000000.0,"fixedAsset":25552000000.0,"tangibleFixedAssets":7917000000.0,"intangibleFixedAssets":1790000000.0,"investmentAndOtherAssets":15843000000.0,"liabilities":6397000000.0,"currentLiabilities":4535000000.0,"shorTermDept":379000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1861000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":60267000000.0,"capitalStock":57290000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":48755000000.0,"treasuryStock":-606000000.0,"valuationAndConversionAdjustments":2976000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":20813000000.0,"costOfSales":9191000000.0,"grossProfit":11621000000.0,"sgaExpenses":10162000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":5380000000.0,"operatingIncome":1459000000.0,"nonOperatingIncome":775000000.0,"nonOperatingExpenses":121000000.0,"interestExpense":12000000.0,"ordinaryProfit":2113000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":2113000000.0,"incomeTaxes":234000000.0,"netIncome":1879000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1879000000.0,"comprehensiveIncome":1857000000.0,"eps":33.31,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/12","stockCode":4548,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":913.0,"averageTemporaryStaff":100.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":29276000.0,"sharesOwendPercent":0.5188,"outstandingShares":null,"numberOfSubsidiary":5.0,"bps":1127.14,"equityRatio":0.91,"cashAndCashEquivalents":15767000000.0,"assets":69915000000.0,"currentAssets":43558000000.0,"fixedAsset":26357000000.0,"tangibleFixedAssets":8302000000.0,"intangibleFixedAssets":2350000000.0,"investmentAndOtherAssets":15703000000.0,"liabilities":6311000000.0,"currentLiabilities":5609000000.0,"shorTermDept":380000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":702000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":63604000000.0,"capitalStock":59749000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":51214000000.0,"treasuryStock":-606000000.0,"valuationAndConversionAdjustments":3854000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":27662000000.0,"costOfSales":12112000000.0,"grossProfit":15549000000.0,"sgaExpenses":14018000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":7209000000.0,"operatingIncome":1530000000.0,"nonOperatingIncome":1517000000.0,"nonOperatingExpenses":23000000.0,"interestExpense":16000000.0,"ordinaryProfit":3024000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":3024000000.0,"incomeTaxes":-1237000000.0,"netIncome":4262000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4262000000.0,"comprehensiveIncome":5119000000.0,"eps":75.54,"dilutedEps":null,"dividendPerShare":null,"per":13.7,"roe":0.069,"cashFlowFromOperatingActivities":1257000000.0,"depreciationAndCashflowFromOperatingActivities":729000000.0,"cashFlowFromInvestingActivities":1023000000.0,"cashFlowFromFinancialActivities":-1507000000.0,"changesInCashAndCashEquivalents":775000000.0,"列1":"asr","submitDate":"2021\/6\/29","stockCode":4548,"accountingYear":"第75期（自 2020年4月1日　至 2021年3月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.896,"cashAndCashEquivalents":null,"assets":75442000000.0,"currentAssets":49196000000.0,"fixedAsset":26246000000.0,"tangibleFixedAssets":8679000000.0,"intangibleFixedAssets":2485000000.0,"investmentAndOtherAssets":15081000000.0,"liabilities":7856000000.0,"currentLiabilities":7059000000.0,"shorTermDept":387000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":797000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":67586000000.0,"capitalStock":62612000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":54077000000.0,"treasuryStock":-606000000.0,"valuationAndConversionAdjustments":4974000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":11784000000.0,"costOfSales":3716000000.0,"grossProfit":8068000000.0,"sgaExpenses":3621000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1936000000.0,"operatingIncome":4446000000.0,"nonOperatingIncome":171000000.0,"nonOperatingExpenses":5000000.0,"interestExpense":3000000.0,"ordinaryProfit":4613000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":4613000000.0,"incomeTaxes":960000000.0,"netIncome":3652000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3652000000.0,"comprehensiveIncome":4772000000.0,"eps":64.73,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/11","stockCode":4548,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":30553000.0,"sharesOwendPercent":0.5432,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.897,"cashAndCashEquivalents":22448000000.0,"assets":76728000000.0,"currentAssets":49942000000.0,"fixedAsset":26786000000.0,"tangibleFixedAssets":9088000000.0,"intangibleFixedAssets":2491000000.0,"investmentAndOtherAssets":15206000000.0,"liabilities":7903000000.0,"currentLiabilities":7124000000.0,"shorTermDept":389000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":779000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":68824000000.0,"capitalStock":63780000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":55440000000.0,"treasuryStock":-802000000.0,"valuationAndConversionAdjustments":5044000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":20530000000.0,"costOfSales":7357000000.0,"grossProfit":13173000000.0,"sgaExpenses":7134000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3802000000.0,"operatingIncome":6038000000.0,"nonOperatingIncome":368000000.0,"nonOperatingExpenses":13000000.0,"interestExpense":6000000.0,"ordinaryProfit":6393000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":6393000000.0,"incomeTaxes":1374000000.0,"netIncome":5019000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5019000000.0,"comprehensiveIncome":6208000000.0,"eps":89.07,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":6949000000.0,"depreciationAndCashflowFromOperatingActivities":414000000.0,"cashFlowFromInvestingActivities":563000000.0,"cashFlowFromFinancialActivities":-1116000000.0,"changesInCashAndCashEquivalents":6680000000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":4548,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0},{"edinetCode":"E00970","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.89,"cashAndCashEquivalents":null,"assets":76344000000.0,"currentAssets":50512000000.0,"fixedAsset":25832000000.0,"tangibleFixedAssets":9348000000.0,"intangibleFixedAssets":2438000000.0,"investmentAndOtherAssets":14045000000.0,"liabilities":8411000000.0,"currentLiabilities":7845000000.0,"shorTermDept":300000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":565000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":67933000000.0,"capitalStock":63278000000.0,"capital":3840000000.0,"capitalSurplus":5301000000.0,"accumulatedEarnings":54938000000.0,"treasuryStock":-802000000.0,"valuationAndConversionAdjustments":4654000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":28145000000.0,"costOfSales":10998000000.0,"grossProfit":17147000000.0,"sgaExpenses":10913000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":5855000000.0,"operatingIncome":6234000000.0,"nonOperatingIncome":688000000.0,"nonOperatingExpenses":17000000.0,"interestExpense":9000000.0,"ordinaryProfit":6905000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":6905000000.0,"incomeTaxes":1541000000.0,"netIncome":5364000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5364000000.0,"comprehensiveIncome":6164000000.0,"eps":95.25,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/10","stockCode":4548,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00970","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":3840,"settlementDate":"2022\/3\/31","submitterName":"生化学工業株式会社","submitterNameEnglish":"SEIKAGAKU CORPORATION","submitterNameKana":"セイカガクコウギョウカブシキガイシャ","location":"千代田区丸の内一丁目６番１号","industory":"医薬品","corporateNumber":9010000000000.0}]